First drug to treat hair loss disorder alopecia OK'd by FDA. Jada Pinkett Smith and Rep. Ayanna Presley have it.
CBSN
The Food and Drug Administration on Monday approved a drug called baricitinib as the first for treating severe alopecia areata, an autoimmune disorder affecting more than 300,000 people in the United States every year.
Alopecia causes either temporary or permanent patchy hair loss that can affect any hair-bearing site of the body, leading to emotional distress. The condition has come to the fore recently through high-profile cases including Hollywood actress Jada Pinkett Smith and Rep. Ayanna Pressley.
"Access to safe and effective treatment options is crucial for the significant number of Americans affected by severe alopecia," said FDA official Kendall Marcus in a statement. "Today's approval will help fulfill a significant unmet need for patients with severe alopecia areata."
Measles is still making headlines in 2025, prompting questions about the life-threatening disease and how to prevent it.
It is common among older adults to not consistently get a full night's rest. But there are ways to improve sleep issues.
Microsoft is pulling the plug on Skype, the pioneering Internet telecommunications and video call platform it bought nearly 14 years ago for $8.5 billion.
Measles cases popping up across the United States, including an outbreak in Texas that has led to the death of a child, are prompting questions about where exactly the illness has been detected.